Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma

Affiliations

¹ Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, Italy. Electronic address: massimo.franchini@asst-mantova.it.
² Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, Italy.
³ Department of Frailty, Carlo Poma Hospital, Mantova, Italy.
⁴ Lung Unit, Carlo Poma Hospital, Mantova, Italy.
⁵ Unit of Infectious Diseases, Carlo Poma Hospital, Mantova, Italy.

Comment

Massimo Franchini et al. Transfus Clin Biol. 2021 Aug.

. 2021 Aug;28(3):309-310.

doi: 10.1016/j.tracli.2021.04.003. Epub 2021 Apr 20.

¹ Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, Italy. Electronic address: massimo.franchini@asst-mantova.it.
² Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, Italy.
³ Department of Frailty, Carlo Poma Hospital, Mantova, Italy.
⁴ Lung Unit, Carlo Poma Hospital, Mantova, Italy.
⁵ Unit of Infectious Diseases, Carlo Poma Hospital, Mantova, Italy.

No abstract available

Comment on

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Chai KL, et al. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4. PMID: 33044747 Updated.

1. Chai K.L., Valk S.J., Piechotta V., et al. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020;10:CD013600. - PubMed
1. Libster R., Pérez Marc G., Wappner D., et al. Early high-titer plasma therapy to prevent severe COVID-19 in older adults. N Engl J Med. 2021;384:610–618. doi: 10.1056/NEJMoa2033700. - DOI - PMC - PubMed
1. Joyner M.J., Carter R.E., Senefeld J.W. Convalescent plasma antibody levels and the risk of death from COVID-19. N Engl J Med. 2021;384:1015–1027. doi: 10.1056/NEJMoa2031893. - DOI - PMC - PubMed
1. Li L., Zhang W., Hu Y., et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. 2020;324:460–470. - PMC - PubMed
1. Weisblum Y., Schmidt F., Zhang F., et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife. 2020;9:e61312. - PMC - PubMed